GlaxoSmithKline (GSK) has received FDA approval for Votrient (pazopanib) for the treatment of patients with advanced soft tissue sarcoma (STS) who have received prior chemotherapy. The approval is based on the results of the randomized, ...
Tags: advanced soft tissue sarcoma, STS, soft tissue sarcomas, GlaxoSmithKline
Jazz Pharmaceuticals has initiated patient dosing in a clinical trial intravenously (IV) administering Erwinaze in acute lymphoblastic leukemia (ALL) patients hypersensitive to asparaginase therapy derived from E. coli. The trial will ...
Tags: pharmeceuticals, clinical, trial intravenously, E.coli
NewLink Genetics has received a notice of allowance for a Japanese patent entitled, Antitumor Vaccination Using Allogeneic Tumor Cells Expressing Alpha (1,3)-Galactosyltransferase. The patent contains pharmaceutical composition claims ...
Tags: NewLink Genetics, galactosyltransferase, antitumor vaccination
Cytocell, a developer of fluorescence in situ hybridization (FISH) probes for use in cancer analysis, has unveiled a ROS1 Breakapart FISH probe test for non-small-cell lung cancer (NSCLC). The molecular cytogenetic test, which utilizes ...
Greenpeace International investigations have revealed dumping of industrial waste water with a wide range of hazardous substances from two Industrial Zones located in China's most important textile manufacturing base. The investigations ...
Tags: industrial waste water, hazardous substances, pollution
Epigenomics has announced results from a comparative study between its blood-based colorectal cancer(CRC)detection test Epi proColon and fecal immunochemical testing(FIT)to demonstrate the non-inferiority of Epi proColon in detection of ...
Tags: Epigenomics, CRC, FIT, Epi proColon
The revolutionary Jay Kordich PowerGrind Pro juicer has changed the way people are juicing by providing more juice and more nutrients per ounce of produce give you more per food dollar. Using it's multi-patented technology of extracting and ...
An alternative test should be developed to determine if the controversial antibiotic nitrofurazone has been used in the production of honey, according to a new review commissioned by the Food Standards Agency in Scotland (FSAS). ...
Tags: the production of honey, controversial antibiotic nitrofurazone
Chronix Biomedical has opened a fully operational sequencing laboratory in Brookings, South Dakota, US, to expand its commercial capabilities. Chronix has opened the laboratory in association with the First Bank & Trust of Brookings, ...
Researchers at the University of Warwick have developed new statistical image analysis method for automatic mitotic cell detection for cancer diagnosis. The new method enables segmenting tumor regions and detecting dividing cells in ...
Tags: statistical image analysis method, automatic mitotic cell detection
Dako, a manufacturer of cancer diagnostics solutions, has received approval from the US Food and Drug Administration to market HercepTest and Her2 Fish pharmDx kit as co diagnostics for pertuzumab (Perjeta), a Genentech cancer drug. ...
Tags: Dako, HER2-positive metastatic breast cance, HER2 FISH pharmDx Kit
Accuray has received 510(k) clearance for its new CyberKnife M6 Series from the US Food and Drug Administration (FDA). Designed for use in stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) treatments, the ...
Tags: FDA, stereotactic radiosurgery, stereotactic body radiation therapy
Inovio Pharmaceuticals has received a US patent covering SynCon vaccine for cervical dysplasias and cancers caused by human papillomavirus (HPV). The patent covers Inovio's synthetic consensus HPV antigens, DNA constructs and vaccines ...
Tags: Inovio Pharmaceuticals, SynCon vaccine, HPV
The Centre for Surgical Invention and Innovation (CSii) at McMaster University has announced additional funding for the next phase of development of MacDonald, Dettwiler and Associates' (MDA) advanced technology solution for use in early ...
Tags: CSii, MDA, treatment of breast cancer
Pfizer has received positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for crizotinib to treat adults with previously treated anaplastic lymphoma kinase (ALK)-positive ...
Tags: Pfizer, CHMP, anaplastic lymphoma kinase